Does Supervised Exercise Offer Adjuvant Benefit Over Exercise Advice Alone for the Treatment of Intermittent Claudication? A Randomised Trial D.R Cheetham, L Burgess, M Ellis, A Williams, R.M Greenhalgh, A.H Davies European Journal of Vascular and Endovascular Surgery Volume 27, Issue 1, Pages 17-23 (January 2004) DOI: 10.1016/j.ejvs.2003.09.012
Fig. 1 Trial design. European Journal of Vascular and Endovascular Surgery 2004 27, 17-23DOI: (10.1016/j.ejvs.2003.09.012)
Fig. 2 Suitability of patients attending vascular out-patients over a 6-month period with symptoms of intermittent claudication to participate in a walking based exercise programme. European Journal of Vascular and Endovascular Surgery 2004 27, 17-23DOI: (10.1016/j.ejvs.2003.09.012)
Fig. 3 Change in ShortForm-36 median physical function score over time. European Journal of Vascular and Endovascular Surgery 2004 27, 17-23DOI: (10.1016/j.ejvs.2003.09.012)
Fig. 4 Mean percent score for Charing Cross Claudication Questionnaire for class and advice groups at baseline, 3, 6 and 12-month review (higher score equates to more severe symptoms). European Journal of Vascular and Endovascular Surgery 2004 27, 17-23DOI: (10.1016/j.ejvs.2003.09.012)
Fig. 5 Mean absolute claudication distance for treadmill walking (constant load, 3.5 km/h at 12% slope) for class and advice groups at baseline, 3, 6 and 12-month review. European Journal of Vascular and Endovascular Surgery 2004 27, 17-23DOI: (10.1016/j.ejvs.2003.09.012)
Fig. 6 Self-reported average weekly frequency of 30 min walks to near maximum pain undertaken in the supervised exercise and advice to exercise groups at 6-month review. European Journal of Vascular and Endovascular Surgery 2004 27, 17-23DOI: (10.1016/j.ejvs.2003.09.012)
Fig. 7 Mean change in CCCQ score (Symptom specific HRQL) over initial 6-month period compared to claimed weekly frequency of walks. European Journal of Vascular and Endovascular Surgery 2004 27, 17-23DOI: (10.1016/j.ejvs.2003.09.012)